Recent advances in the molecular biology of Hepatitis C virus

被引:153
作者
Rosenberg, S [1 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
关键词
hepatitis C virus; subgenomic replicons; infectious RNA; interferon; antivirals;
D O I
10.1006/jmbi.2001.5055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Hepatitis C virus is a positive-stranded RNA virus which is the causal agent for a chronic liver infection afflicting more than 170,000,000 people world-wide. The HCV genome is approximately 9.6 kb in length and the proteome encoded is a polyprotein of a little more than 3000 amino acid residues. This polyprotein is processed by a combination of host and viral proteases into structural and non-structural proteins. The functions of most of these proteins have been established by analogy to other viruses and by sequence homology to known proteins, as well as subsequent biochemical analysis. Two of the non-structural proteins, NS4b and NS5a, are still of unknown function. The development of antivirals for this infectious agent has been hampered by the lack of robust and economical cell culture and animal infection systems. Recent progress in the molecular virology of HCV has come about due to the definition of molecular clones, which are infectious in the chimpanzee, the development of a subgenomic replicon system in Huh? cells, and the description of a transgenic mouse model for HCV infection. Recent progress in the structural biology of the virus has led to the determination of high resolution three-dimensional structures of a number of the key virally encoded enzymes, including the NS3 protease, NS3 helicase, and NS5b RNA-dependent RNA polymerase. In some cases these structures have been determined in complex with substrates, co-factors (NS4a), and inhibitors. Finally, a variety of techniques have been used to define host factors, which may be required for HCV replication, although this work is just beginning. (C) 2001 Academic Press.
引用
收藏
页码:451 / 464
页数:14
相关论文
共 141 条
[1]   Perspectives for a vaccine against hepatitis C virus [J].
Abrignani, S ;
Houghton, M ;
Hsu, HH .
JOURNAL OF HEPATOLOGY, 1999, 31 :259-263
[2]   Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor [J].
Agnello, V ;
Abel, G ;
Elfahal, M ;
Knight, GB ;
Zhang, QX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12766-12771
[3]   Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus [J].
Ago, H ;
Adachi, T ;
Yoshida, A ;
Yamamoto, M ;
Habuka, N ;
Yatsunami, K ;
Miyano, M .
STRUCTURE, 1999, 7 (11) :1417-1426
[4]   The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase [J].
Attwood, MR ;
Bennett, JM ;
Campbell, AD ;
Canning, GGM ;
Carr, MG ;
Conway, E ;
Dunsdon, RM ;
Greening, JR ;
Jones, PS ;
Kay, PB ;
Handa, BK ;
Hurst, DN ;
Jennings, NS ;
Jordan, S ;
Keech, E ;
O'Brien, MA ;
Overton, HH ;
King-Underwood, J ;
Raynham, TM ;
Stenson, KP ;
Wilkinson, CS ;
Wilkinson, TCI ;
Wilson, FX .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1999, 10 (05) :259-273
[5]   Specific interaction of hepatitis C virus protease/helicase NS3 with the 3′-terminal sequences of viral positive- and negative-strand RNA [J].
Banerjee, R ;
Dasgupta, A .
JOURNAL OF VIROLOGY, 2001, 75 (04) :1708-1721
[6]   Inhibitor binding induces active site stabilization of the HCVNS3 protein serine protease domain [J].
Barbato, G ;
Cicero, DO ;
Cordier, F ;
Narjes, F ;
Gerlach, B ;
Sambucini, S ;
Grzesiek, S ;
Matassa, VG ;
De Francesco, R ;
Bazzo, R .
EMBO JOURNAL, 2000, 19 (06) :1195-1206
[7]   The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism [J].
Barbato, G ;
Cicero, DO ;
Nardi, MC ;
Steinkühler, C ;
Cortese, R ;
De Francesco, R ;
Bazzo, R .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (02) :371-384
[8]   The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy [J].
Bartenschlager, R .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) :165-181
[9]   Replication of hepatitis C virus [J].
Bartenschlager, R ;
Lohmann, V .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :1631-1648
[10]   KINETIC AND STRUCTURAL-ANALYSES OF HEPATITIS-C VIRUS POLYPROTEIN PROCESSING [J].
BARTENSCHLAGER, R ;
AHLBORNLAAKE, L ;
MOUS, J ;
JACOBSEN, H .
JOURNAL OF VIROLOGY, 1994, 68 (08) :5045-5055